Structures by: Mahendiran D.
Total: 8
Pyridazine hydrazine compound
C15H18ClN5O
New J. Chem. (2016) 40, 3 2451
a=6.7997(5)Å b=9.5387(8)Å c=24.3565(19)Å
α=90.00° β=95.512(8)° γ=90.00°
C33.5H30ClCuN3O5.5
C33.5H30ClCuN3O5.5
New J. Chem. (2015) 39, 10 7895
a=8.590(5)Å b=10.579(5)Å c=18.094(5)Å
α=83.522(5)° β=84.936(5)° γ=69.681(5)°
C37H34ClCuN3O4
C37H34ClCuN3O4
New J. Chem. (2015) 39, 10 7895
a=8.6469(7)Å b=34.562(3)Å c=11.4333(10)Å
α=90° β=109.165(5)° γ=90°
Hydroxy thiosemicarbazide derivative
C9H11N3OS
RSC Advances (2018) 8, 30 16973
a=6.885(3)Å b=7.108(3)Å c=11.230(4)Å
α=74.336(4)° β=76.662(4)° γ=73.802(4)°
Benzimidazole Phthalamide compound
C23H17N5O6
RSC Adv. (2016)
a=8.5032(5)Å b=12.9483(7)Å c=18.8575(11)Å
α=90.00° β=98.797(3)° γ=90.00°
C26H50Br2Cl4Cu2N6O9
C26H50Br2Cl4Cu2N6O9
RSC Advances (2014)
a=13.8391(4)Å b=14.3968(4)Å c=20.2234(7)Å
α=90.00° β=98.6740(10)° γ=90.00°
C15H28BrCl2N3NiO4
C15H28BrCl2N3NiO4
RSC Advances (2014)
a=10.1699(4)Å b=16.8523(8)Å c=24.8924(11)Å
α=90.00° β=98.768(2)° γ=90.00°
C45H50Cl2CuN6O9
C45H50Cl2CuN6O9
Dalton transactions (Cambridge, England : 2003) (2016) 45, 18 7794-7814
a=16.0226(4)Å b=16.0226(4)Å c=34.0974(12)Å
α=90° β=90° γ=120°